Home › NDC Lookup › RxCUI directory › RxCUI 1741907

Dapsone 0.075 MG/MG Topical Gel [Aczone] — RxCUI 1741907

RxNorm drug concept · Semantic branded drug
RxCUI 1741907 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1741907
Official nameDapsone 0.075 MG/MG Topical Gel [Aczone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAczone 7.5 % Topical Gel; Aczone 0.075 MG/MG Topical Gel
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dapsone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Aczone gel is a prescription topical treatment for acne vulgaris — the kind of acne that causes pimples, blackheads, and inflamed spots on the face, chest, back, and shoulders. It'...
  • Start with clean, dry skin — gently wash the area and pat it dry. Then squeeze out about a pea-sized amount of gel and spread a thin layer over the acne-affected areas. Rub it in g...
  • Possibly, yes — this is a real, known interaction. If you apply benzoyl peroxide after dapsone gel, some people do get a temporary yellow or orange tint on their skin or facial hai...
  • Will it turn my skin yellow if I also use benzoyl peroxide?
📖 Read our full Dapsone Topical guide →

🕸️ Concept Web — How Dapsone 0.075 MG/MG Topical Gel [Aczone] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dapsone 0.075 MG/MG Topical Gel [Aczone] RxCUI 1741907

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dapsone 3108
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aczone 605173
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dapsone Topical Gel 607294
    • Dapsone Topical Product 1152142
    • Dapsone Topical Gel [Aczone] 701857
    • Aczone Topical Product 1169951
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dapsone 0.075 MG/MG Topical Gel SCD · 1741905
  • Dapsone 0.075 MG/MG SCDC · 1741904
  • Dapsone Topical Gel SCDF · 607294
  • Dapsone Topical Product SCDG · 1152142

Brand-Name Concepts

  • Dapsone 0.075 MG/MG [Aczone] SBDC · 1741906
  • Dapsone Topical Gel [Aczone] SBDF · 701857
  • Aczone Topical Product SBDG · 1169951
  • Aczone BN · 605173

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1741907 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16110-0526-60 1 BOTTLE, PUMP in 1 CARTON (16110-526-60) / 60 g in 1 BOTTL... Aczone Almirall, LLC 2019-09-10
16110-0526-90 1 BOTTLE, PUMP in 1 CARTON (16110-526-90) / 90 g in 1 BOTTL... Aczone Almirall, LLC 2019-09-10
Observed labelers: Almirall, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.